Literature DB >> 9593133

Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.

C Martin1, A Cotin, A Giraud, M Beccani-Argème, P Alliot, M N Mallet, M Argème.   

Abstract

The concentrations of sulbactam and ampicillin were determined in sera and different abdominal tissues of 16 patients who underwent elective colorectal surgery. Patients were randomly allocated to two groups. At the time of induction of anesthesia, patients in group 1 (eight patients) were given 1,000 mg of sulbactam with 2,000 mg of ampicillin by intravenous bolus injection (3 min). This dose was administered again after 2 h by bolus injection by the same route. Patients in group 2 (eight patients) were given the same initial dose of sulbactam-ampicillin by bolus injection (3 min). Then, a continuous infusion of 1,000 mg of sulbactam with 2,000 mg of ampicillin in normal saline was immediately started and was administered over a 4-h period. Blood samples were collected to determine peak (10 min) and trough (end of surgery) antibiotic levels. Serial blood samples were also collected at predetermined periods (at the time of opening and closing of the abdominal cavity and at the time of surgical anastomosis). Abdominal wall fat, epiploic fat, and colonic wall tissue samples were collected simultaneously. Antibiotic concentrations were determined by high-performance liquid chromatography. Similar levels of the drugs in serum were observed for the two regimens of administration, with trough sulbactam levels of 33 +/- 16 and 37 +/- 22 microg/ml in groups 1 and 2, respectively, and trough ampicillin levels of 72 +/- 55 and 79 +/- 47 microg/ml in groups 1 and 2, respectively. Similar sulbactam concentrations were observed in abdominal tissues whichever regimen of administration was used; in fatty tissues the sulbactam concentrations ranged from 2.7 to 3.8 microg/g for group 1 and from 1.7 to 4.0 microg/g for group 2, and sulbactam concentrations in the colonic wall were 5.6 +/- 7.7 and 6.8 +/- 3.2 microg/g in groups 1 and 2, respectively (not significant). Again, no influence of the regimen of administration was observed on tissue ampicillin concentrations; in fatty tissues ampicillin concentrations ranged from 4.1 to 5.4 microg/g for group 1 and from 3.2 to 5.8 microg/g for group 2, and sulbactam concentrations in the colonic wall were 7.0 +/- 2.8 and 11.0 +/- 4.7 microg/g for groups 1 and 2, respectively (not significant). In most patients, the concentrations of ampicillin-sulbactam were greater than the MIC at which 50% of isolates are inhibited (MIC50) for Bacteroides fragilis in the fatty tissues. In the colonic wall, for most patients the concentrations of ampicillin-sulbactam were greater than the MIC90 for B. fragilis. No influence of the regimen of administration was observed on the ratio of the two components in the tissues investigated and in sera. In conclusion, a second intraoperative bolus injection or a continuous infusion were equally effective in maintaining sulbactam-ampicillin concentrations in abdominal tissues. The first method of administration can be recommended since it is easier to handle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593133      PMCID: PMC105751          DOI: 10.1128/AAC.42.5.1093

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

2.  Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.

Authors:  E T Houang; N Colley; M Chapman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 3.  Antimicrobial prophylaxis in surgery.

Authors:  A B Kaiser
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

Review 4.  Beta-lactamases.

Authors:  A A Medeiros
Journal:  Br Med Bull       Date:  1984-01       Impact factor: 4.291

5.  A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls.

Authors:  M L Baum; D S Anish; T C Chalmers; H S Sacks; H Smith; R M Fagerstrom
Journal:  N Engl J Med       Date:  1981-10-01       Impact factor: 91.245

6.  Sulbactam/ampicillin compared with cefoxitin for chemoprophylaxis in elective colorectal surgery.

Authors:  M N de la Hunt; S J Karran
Journal:  Dis Colon Rectum       Date:  1986-03       Impact factor: 4.585

7.  Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; S Sjöstedt; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

8.  Basic principles in the use of prophylactic antibiotics.

Authors:  H H Stone
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

9.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

10.  Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.

Authors:  H J ROgers; I D Bradbrook; P J Morrison; R G Spector; D A Cox; L J Lees
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

View more
  6 in total

1.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

Review 2.  Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters.

Authors:  Sofia K Kasiakou; Kenneth R Lawrence; Nicolaos Choulis; Matthew E Falagas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

Review 4.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Kenneth H Rand; Herbert J Houck
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 6.  Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

Authors:  Jennifer Shiu; Erica Wang; Aaron M Tejani; Michael Wasdell
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.